The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Cancer Stem Cell Hierarchy in Glioblastoma Multiforme
Open accessAbstract
Glioblastoma multiforme (GBM), an aggressive tumor that typically exhibits treatment failure with high mortality rates, is associated with the presence of cancer stem cells (CSCs) within the tumor. CSCs possess the ability for perpetual self-renewal and proliferation, producing downstream progenitor cells that drive tumor growth. Studies of many cancer types have identified CSCs using specific markers, but it is still unclear as to where in the stem cell hierarchy these markers fall. This is compounded further by the presence of multiple GBM and glioblastoma cancer stem cell subtypes, making investigation and establishment of a universal treatment difficult. This review examines the current knowledge on the CSC markers SALL4, OCT-4, SOX2, STAT3, NANOG, c-Myc, KLF4, CD133, CD44, nestin, and glial fibrillary acidic protein, specifically focusing on their use and validity in GBM research and how they may be utilized for investigations into GBM's cancer biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–225 of 225
Ratajczak, M. Z., Kucia, M., Majka, M., Reca, R., & Ratajczak, J. (2004) · PubMed · doi:10.5603/4649 · Cited by 86
Cao, F., Hata, R., Zhu, P., Nakashiro, K., & Sakanaka, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.092 · Cited by 85
Overexpression of SALL4 in lung cancer and its importance in cell proliferation
Watanabe, N. (2011) · Oncology Reports · doi:10.3892/or.2011.1374 · Cited by 85
Pituitary stem /progenitor cells: embryonic players in the adult gland?
Vankelecom, H. E. J. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07523.x · Cited by 82
Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., & Altaba, A. R. I. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.024 · Cited by 80
Gariboldi, M. B., Ravizza, R., & Monti, E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.011 · Cited by 79
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma
Liu, Q., Liu, Y., Li, W., Wang, X., Sawaya, R. A., Lang, F. F., Yung, W. K. A., Chen, K., Fuller, G. N., & Zhang, W. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1470-8 · Cited by 76
Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes
Asher, R., & Bignami, A. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90042-7 · Cited by 75
Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4
He, J., Zhang, W., Zhou, Q., Zhao, T., Song, Y., Chai, L., & Li, Y. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.008 · Cited by 73
Shin, S., Sun, Y., Liu, Y., Khaner, H., Svant, S., Cai, J., Xu, Q., Davidson, B. P., Stice, S. L., Smith, A. K., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0660 · Cited by 72
A new era for Journal of Experimental & Clinical Cancer Research
Castelli, M. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-1 · Cited by 69
Piccirillo, S. G. M., Binda, E., Fiocco, R., Vescovi, A. L., & Shah, K. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0535-3 · Cited by 68
Broers, J. L. V., Viallet, J., Jensen, S., Pass, H. I., Travis, W. D., Minna, J. D., & Linnoila, R. I. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/9.1.33 · Cited by 66
Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma
Morokoff, A. P., Ng, W., Gogos, A., & Kaye, A. H. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.02.008 · Cited by 64
A paired comparison between glioblastoma “stem cells” and differentiated cells
Schneider, M. B., Ströbele, S., Nonnenmacher, L., Siegelin, M. D., Tepper, M., Stroh, S., Hasslacher, S., Enzenmüller, S., Strauß, G., Baumann, B., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29908 · Cited by 63
Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas
Dietrich, J., Imitola, J., & Kesari, S. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1132 · Cited by 60
Expression of variant CD44 epitopes in human astrocytic brain tumors
Eibl, R. H., Pietsch, T., Moll, J., Skroch, P., Heider, K., Ammon, K. V., Wiestler, O. D., Ponta, H., Kleihues, P., & Herrlich, P. A. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01052619 · Cited by 57
Breyer, R., Hussein, S., Radu, D. L., Pütz, K.-M., Gunia, S., Hecker, H., Samii, M., Walter, G. F., & Stan, A. C. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.92.1.0140 · Cited by 53
Expression and Clinical Significance of STAT3, P-STAT3, and VEGF-C in Small Cell Lung Cancer
Zhao, X., Sun, X. W., & Li, X. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.6.2873 · Cited by 48
Zhang, L., Yan, Y., Jiang, Y., Cui, Y., Zou, Y., Qian, J., Luo, C., Lu, Y., & Wu, X. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1646-4 · Cited by 48
Jha, P., Patric, I. R. P., Shukla, S. K., Pathak, P., Pal, J., Sharma, V., Thinagararanjan, S., Santosh, V., Suri, V. S., Sharma, M. C., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou113 · Cited by 35
Multi-functional roles of Stat3 revealed by conditional gene targeting.
Takeda, K., & Akira, S. (2001) · PubMed · Cited by 25
Diagnostic markers for glioblastoma.
Jung, C. S., Unterberg, A. W., & Hartmann, C. J. (2011) · PubMed · doi:10.14670/hh-26.1327 · Cited by 17
The Cancer Stem Cell Hypothesis
Foreman, K. E., Rizzo, P., Osipo, C., & Miele, L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-933-8_1 · Cited by 16
(2003) · PubMed
Cited by
Ludwig, K., & Kornblum, H. I. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2379-y · Cited by 418
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
Tomaszewski, W., Sanchez-Perez, L., Gajewski, T. F., & Sampson, J. H. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1627 · Cited by 319
Glioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
Yi, Y., Hsieh, I.-Y., Huang, X., Li, J., & Zhao, W. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00477 · Cited by 105
Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
Her, N.-G., Oh, J.-W., Oh, Y. J., Han, S., Cho, H. J., Lee, Y., Ryu, G. H., & Nam, D.-H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0825-1 · Cited by 68
Metadata
- Authors
- Bradshaw, A., Wickremsekera, A., Tan, S. T., Peng, L., Davis, P. F., & Itinteang, T.
- Venue
- Frontiers in Surgery
- Publisher
- Frontiers Media SA
- Published
- 2016-04-15
- Volume
- 3
- Pages
- 21-21
- ISSN
- 2296-875X (ISSN-L)
- OpenAlex
- W2340024299
- Cited by
- 258
- References
- 225
- FWCI
- 16.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.